Zalipsky et al., FEBS Letters 353, 71-74, 1994.* |
Papahadjopoulos et al., PNAS, vol. 88, pp. 11460-11464, 1991.* |
Blume et al, Biochimica et Biophysica Acta, 1029, 91-97, 1990.* |
Klibanov e al., FEBS, vol. 268, 1, 235-237, 1990.* |
J. Harms et al., “Interferon-y Inhibits Transgene Expression Driven by SV40 or CMV Promoters but Augments Expression Driven by the Mammalian MHC I Promoter,” Human Gene Therapy, 6 (1995), pp. 1291-1297. |
C. Kunsch et al., “NF-κB Subunit-Specific Regulation of the Interleukin-8 Promoter,” Molecular and Cellular Biology, 13 (1993), pp. 6137-6146. |
T. Libermann et al., “Activation of the Interleukin-6 Gene Expression through the NF-κB Transcription Factor,” Molecular and Cellular Biology, 10 (1990), pp. 2327-2334. |
N. Mukaida et al., “Cooperative Interaction of Nuclear Factor-κB- and Cis—Regulatory Enhancer Binding Protein-like Factor Binding Elements in Activating the Interleukin-8 Gene by Pro-inflammatory Cytokines,” The Journal of Biological Chemistry, 265 (1990), pp. 21128-21133. |
H. Nakarnura et al., “Interleukin-8 Gene Expression in Human Bronchial Epithelial Cells,” The Journal of Biological Chemistry, 266 (1991), pp. 19611-19617. |
J. Nakano et al., “Endotoxin and Pro-inflammatory Cytokines Stimulate Endothelin-1 Expression and Release by Airway Epithelial Cells,” Clinical and Experimental Allergy, 24 (1994), pp. 330-336. |
A. Ray et al., “Activation of the Human ′β2-interferon/Hepatocyte-stimulating Factor/Interleukin 6′ Promoter by Cytokines, Viruses, and Second Messenger Agonists,” Proceedings of the National Academy of Sciences USA, 85 (1988), pp. 6701-6705. |
R. Robbins et al., “Inducible Nitric Oxide Synthase is Increased in Murine Lung Epithelial Cells By Cytokine Stimulation,” Biochemical and Biophysical Research Communications, 198 (1994), pp. 835-843. |
C. Ruef et al., “Regulation of Cytokine Secretion by Cystic Fibrosis Airway Epithelial Cells,” European Respiratory Journal, 6 (1993), pp. 1429-1436. |
A. Schuster et al., “Cytokines in Nuetrophil-dominated Airway Inflammation in Patients with Cystic Fibrosis,” European Archives of Otorhinolaryngology, 252 (suppl. 1), (1995), pp. S59-S60. |
J. Guy-Caffey et al., “Novel Polyaminolipids Enhance the Cellular Uptake of Oligonucleotides,” The Journal of Biological Chemistry, 270 (1995), pp. 31391-31396. |
J. Janne, et al., “Polyamines: From Molecular Biology to Clinical Applications,” Annals of Medicine , 23 (1991), pp. 241-259. |
N. Caplen, et al., “Liposome Mediated CFTR Gene Transfer to the Nasal Epithelium of Patients With Cystic Fibrosis,” Nature Medicine, 1 (1995), pp. 39-46. |
J-S. Remy et al., “Gene Transfer with a Series of Lipophilic DNA Binding Molecules,” Bioconjugate Chemistry, 5 (1994), pp. 647-654. |
J-P. Behr, “Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy,” Bioconjugate Chemistry, 5 (1994), pp. 382-389. |
J. Felgner, et al., “Enhanced Gene Delivery and Mechanism Studies with a Novel Series of Cationic Lipid Formulations,” The Journal of Biological Chemistry, 269 (1994), pp. 2550-2561. |
Barthel et al., “Gene Transfer Optimization with Lipospermine-Coated DNA,” DNA and Cell Biology, 12 (1993), pp. 553-560. |
J-P. Behr, “Synthetic Gene-Transfer Vectors,” Accounts of Chemical Research, 26 (1993), pp. 274 -278. |
P. Hoet, et al., “Kinetics and Cellular Localization of Putrescine Uptake in Human Lung Tissue,” Thorax, 48 (1993), pp. 1235-1241. |
J. Felgner, et al., “Cationic Lipid-Mediated Delivery of Polynucleotides,” Methods (A Companion to Methods in Enzymology), 5 (1993), pp. 67-75. |
X. Gao, et al., “A Novel Cationic Liposome Reagent for Efficient Transfection of Mammalian Cells,” Biochemical and Biophysical Research Communications, 179 (1991), pp. 280-285. |
J. Rose, et al., “A New Cationic Liposome Reagent Mediating Nearly Quantitative Transfection of Animal Cells,” Biotechniques, 10 (1991), pp. 520-525. |
J. Loeffler, et al., “Lipopolyamine-Mediated Transfection Allows Gene Expression Studies in Primary Neuronal Cells,” Journal of Neurochemistry, 54 (1990), pp. 1812-1815. |
J. Cheetam, et al., “Cholesterol Sulfate Inhibits the Fusion of Sendai Virus to Biological and Model Membranes,” The Journal of Biological Chemistry, 265 (1990), pp. 12404-12409. |
J-P. Behr, et al., “Efficient Gene Transfer into Mammalian Primary Endocrine Cells with Lipopolyamine-Coated DNA,” Proceedings of the National Academy of Science USA, 86 (1989), pp. 6982-6986. |
R. Letsinger, et al., “Cholesteryl-Conjugated Oligonucleotides: Synthesis, Properties, and Activity as Inhibitors of Replication of Human Immunodeficiency Virus in Cell Culture,” Proceedings of the National Academy of Sciences USA, 86 (1989), pp. 6553-6556. |
L. Stamatatos, et al., “Interactions of Cationic Lipid Vesicles with Negatively Charged Phospholipid Vesicles and Biological Membranes,” Biochemistry, 27 (1988), pp. 3917-3925. |
P. Felgner, et al., “Lipofection: A Highly Efficient, Lipid-Mediated DNA-Transfection Procedure,” Proceedings of the National Academy of Sciences USA, 84 (1987), pp. 7413-7417. |
R. Rando, et al., “The Synthesis and Properties of a Functional Fluorescent Cholesterol Analog,” Biochemica et Biophysica Acta, 684 (1982), pp. 12-20. |
A. Pegg, “Polyamine Metabolism and its Importance in Neoplastic Growth and as a Target for Chemotherapy,” Cancer Research, 48 (1988), pp. 759-774. |
R. Kameji, et al., “Spermidine Uptake by Type II Pulmonary Epithelial Cells in Primary Culture,” American Journal of Physiology, 256 (1989), pp. C161-C167. |
K. Patel et al., “Modification of Vesicle Surfaces with Amphiphilic Sterols. Effect on Permeability and In Vivo Tissue Distribution,” Biochimica et Biophysica Acta, 814 (1985), pp. 256-264. |
K. Moore et al., “Squalamine: An Aminosterol Antibiotic from the Shark”, Proceedings of the National Academy of Sciences USA, 90 (1993), pp. 1354-1358. |
X. Zhou et al., “DNA Transfection Mediated by Cationic Liposomes Containing Lipopolylysine: Characterization and Mechanism of Action,” Biochimica et Biophysica Acta, 1189, 1994, pp. 195-203. |
A. Tari et al., “Structure and Function Relationship of Phosphatidylglycerol in the Stabilization of the Phosphatidylethanolamine Bilayer,” Biochemistry, 29, 1989, pp. 7708-7712. |
H. Farhood et al., “The Role of Dioleoyl Phosphatidylethanolamine in Cationic Liposome Mediated Gene Transfer,” Biochemica et Biophysica Acta, 1235, 1995, pp. 289-295. |
P. Brown et al., “Role of Head Group Structure in the Phase Behavior of Amino Phospholipids. 2. Lamellar and Nonlamellar Phases of Unsaturated Phosphatidylethanolamine Analogues,” Biochemistry, 25, 1986, pp. 4259-4267. |
S. Walker et al., “Cationic Facial Amphiphiles: A Promising Class of Transfection Agents,” Proceedings of the National Academy of Sciences USA, 93, 1996, pp. 1585-1590. |
R. Leventis et al., “Interactions of Mammalian Cells with Lipid Dispersions Containing Novel Metabolizable Cationic Amphiphiles,” Biochemica et Biophysica Acta, 1023, 1990, pp. 123-132. |
Bennett et al., “Cholesterol Enhances Cationic Liposome-Mediated DNA Transfection of Human Respiratory Epithelial Cells,” Bioscience Reports, vol. 15, No. 1 (1995). |
Li et al., “DC-Chol Lipid System in Gene Transfer,” Journal of Controlled Release, 39, 373-381 (1996). |
Behr et al., “Efficient Gene Transfer into Mammalian Primary Endocrine Cells with Lipopoly-amine-coated DNA,” Proc. Natl. Acad. Sci., vol. 86, pp. 6982-6986 (1989). |
Egilmez et al., “Evaluation and Optimization of Different Cationic Liposome Formulations for in Vivo Gene Transfer,” Biochemical and Biophysical Research Communication, 221, 169-173 (1996). |
Guo et al., “Cationic Liposome Containing Noncytotoxic Phospholipid and Cholesterol Derivatives,” Journal of Liposomes Research, 3(1), pp. 51-70 (1993). |
Moradpour et al., “Efficient Gene Transfer into Mammalian Cells with Cholesteryl-Spermidine,” Biochemical and Piophysical Research Communcations, 221, pp. 82-88 (1986). |
Takeuchi et al., “Effect of Zeta Potential of Cationic Liposomes Containing Cationic Cholesterol Deratives on Gene Transfection,” FEBS Letters, 397, pp. 207-209 (1996). |
Liu et al., “New Cationic Lipid Formulations for Gene Transfer,” Pharmaceuticals Research, vol. 13, No. 12 (1996). |
Lee et al., “Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung,” Human Gene Therapy, 7, pp. 1701-1717 (1996). |
Vigneron et al., “Guanidinium-cholesterol Cationic Lipids: Efficient Vectors for the Transfection of Eukaryotic Cells,” Proc. Natl. Acad. Sci., vol. 93, pp. 9682-9686 (1996). |
Weignberg, Robert A., “The Retinoblastoma Protein and Cell Cycle Control,” Cell, vol. 81, pp. 323-330 (1995). |
Zalipsky et al., Long Circulating, Cationic Liposomes Containing Amino-PEG-Phosphatidylethanolamine, FEBS Letters, 353, 71-74 (1994). |
Woodle et al., “Sterically Stabilized Liposome Therapeutics,” Advanced Drug Delivery Reviews, 16, 249-265 (1995). |
Sunamoto et al., Abstr. Pap. Chem. Soc.: 200 Meet., Pt. 2, POLY 44, (1990), Biotechds Database, AN 91-03655, (1990). |
Zelphati et al., “Liposomes as a Carrier for Intracellular Delivery of Antisense Oligonucleotides: a Real or Magic Bullet,” J. of Controlled Release, 41, 99-119 (1996). |
Ledley, “Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products,” Human Gene Therapy, 6, pp. 1129-1144 (1995). |
T. Standiford et al., “Interleukin-8 Gene Expression by a Pulmonary Epithelial Cell Line—A Model for Cytokine Networks in the Lung” Journal of Clinical Investigation, 86 (1990), pp. 1945-1953. |
A. Stadnyk, “Cytokine Production By Epithelial Cells,” The FASEB Journal 8, (1994), pp. 1041-1047. |
K. Adler et al., “Interactions Between Respiratory Epithelial Cells and Cytokines: Relationships to Lung Inflammation,” Annals of the New York Academy of Sciences, 725 (1994), pp. 128-145. |
Crystal, “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,” Science, vol. 270, pp. 404-410 (1995). |
K. Brigham et al., “In Vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene Using a Loposome Vehicle,” The AmericanJournal of Medical Sciences, 298, pp. 278-281 (1989). |
M. Stewart et al., “Gene Transfer In Vivo with DNA-Liposome Complexes: Safety and Acute Toxicity in Mice,” Human Gene Therapy, 3, pp. 267-275 (1992). |
H. San et al., “Safety and Short-Term Toxicity of a Novel Cationic Lipid Formulation for Human Gene Therapy,” Human Gene Therpay, 4, pp. 781-788 (1993). |
K. Brigham et al., “Rapid Communication: Expression of Human Growth Hormone Fusion Genes in Cultured Lung Endothelial Cells and in the Lungs of Mice,” American Journal of Respiratory Cell & Molecular Biology, 8, pp. 209-213 (1993). |
A. Canonico et al., “Aerosol and Intravenous Transfection of Human α1-Antitrypsin Gene to Lungs of Rabbits,” American Journal of Respiratory Cell & Molecular Biology, 10, pp. 24-29 (1994). |
J. Conary et al., “Protection of Rbbit Lungs from Endotoxin Injury by In Vivo Hyperexpression of the Prostaglandin G/H Synthase Gene,” The Journal of Clinical Investigation, 93, pp. 1834-1840 (1994). |
Y. Liu et al., “Cationic Liposome-mediated Intravenous Gene Delivery,” The Journal of Biological Chemistry, 270, pp. 24864-24870 (1995). |
G. McLachlan et al., “Evaluation In Vitro and In Vivo of Cationic Liposome-expression Construct Complexes for Cystic Fibrosis Gene Therapy,” Gene Therapy, 2, pp. 614-622 (1995). |
M. Tsukamoto et al., “Gene Transfer and Expression in Progeny After Intravenous DNA Injection into Pregnant Mice,” Nature Genetics, 9, pp. 243-248 (1995). |
R. Mahato et al., “In Vivo Disposition Characteristics of Plamsid DNA Complexed with Cationic Liposomes,” Journal of Drug Targeting, 3, pp. 149-157 (1995). |
D. Lew et al., “Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice,” Human Gene Therapy, 6, pp. 553-564 (1995). |
A. Thierry et al., “Systemic Gene Therapy: Biodistribution and Long-term Expression of Transgene in Mice,” Proceedings of the National Academy of Sciences USA, 92, pp. 9742-9746 (1995). |